Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality — José Miguel Rivera‐Caravaca (2018) | RDL Network
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality
Article 2018 en
Authors
JR
José Miguel Rivera‐Caravaca
FM
Francisco Marı́n
ME
María Asunción Esteve‐Pastor
Abstract
1 min read
In AF patients, the risk of bleeding is higher when antiplatelet therapy is combined with acenocoumarol, but the risk of mortality and stroke was not significantly different from that of patients taking only acenocoumarol.
Pietro Caliandro, Virginia Cancelloni, M. De Marco, Giuseppe Reale, Aurelia Zauli, Giancarlo Agnelli, Valeria Caso, Cecilia Becattini, Paolo Calabresi, Maria Giulia Mosconi, Michela Giustozzi, Georgios Tsivgoulis, David Seiffge, Stefan T. Engelter, Philippe Lyrer, Alexandros A. Polymeris, Tolga Dittrich, Annaelle Zietz, Gian Marco De Marchis, Jukka Putaala, Daniel Strbian, Liisa Tomppo,
Discussion(0)
No comments yet. Be the first to comment.